Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy Gilbert

Start price
€291.70
23.09.21 / 50%
Target price
-
23.09.25
Performance (%)
-67.72%
End price
€94.16
12.01.24
Summary
This prediction ended on 12.01.24 with a price of €94.16. Massive losses of -67.72% were the result for the BUY prediction by Gilbert. Gilbert has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
BioNTech SE ADR 7.896% 7.896% 243.124%
iShares Core DAX® 2.112% -0.367% 13.466%
iShares Nasdaq 100 -2.197% -3.794% 38.426%
iShares Nikkei 225® -1.555% -7.320% 18.451%
iShares S&P 500 -0.472% -2.078% 27.488%

According to Gilbert what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
Growths faster than the competition
Could be worthwhile Investment >10% per year
Cons
High risks in the balance sheet

Comments by Gilbert for this prediction

In the thread Biontech SE diskutieren

Buy BioNTech SE ADR

Stopped prediction by Gilbert for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€378.60
10.08.21
-
10.08.24
2.06%
10.08.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€184.50
09.07.21
-
09.07.22
-0.11%
09.07.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€162.50
10.05.21
-
10.05.26
1.60%
27.05.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€125.05
17.04.21
-
17.04.23
5.28%
06.05.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€99.38
08.02.21
-
08.02.22
26.58%
16.04.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
BioNTech SE ADR

Start price
Target price
Perf. (%)
€96.99
08.02.21
-
08.02.22
2.46%
08.02.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€84.76
13.01.21
€103.00
14.43%
08.02.21

Innovative
Market Leader or Top 3
Revenue growth > 30% per year expected
High risks in the balance sheet